Parosmia
Showing 1 - 25 of 189
Parosmia Trial in London (Stellate Ganglion Block, Placebo)
Not yet recruiting
- Parosmia
- Stellate Ganglion Block
- Placebo
-
London, Ontario, CanadaSt. Joseph's Hospital London
Sep 22, 2023
Triggers for Post-Viral Parosmia
Suspended
- Parosmia
- Smell Disorder
-
Reading, United KingdomUniversity of Reading
Sep 5, 2021
Hyposmia, COVID-19, Parosmia Trial in Trois-Rivières (Smell training)
Recruiting
- Hyposmia
- +4 more
- Smell training
-
Trois-Rivières, Quebec, CanadaUniversité du Québec à Trois-Rivières
May 20, 2022
COVID-19-Associated Olfactory Dysfunction, Anosmia, Hyposmia Trial (Stellate Ganglion Block)
Completed
- Anosmia
- +3 more
- Stellate Ganglion Block
-
Saint Louis, MissouriWashington University School of Medicine/Barnes Jewish Hospital
Jan 5, 2023
COVID-19, Olfactory Disorder, Anosmia Trial in Saint Louis (Gabapentin gelatin capsules 300mg, Placebo)
Enrolling by invitation
- COVID-19
- +4 more
- Gabapentin gelatin capsules 300mg
- Placebo
-
Saint Louis, MissouriWashington University
Jun 16, 2022
Anosmia, Covid19, Hyposmia Trial in Roma (co-ultraPEALut, Olfactory Rehab)
Completed
- Anosmia
- +4 more
- co-ultraPEALut
- +3 more
-
Roma, ItalyMulticentric
Nov 12, 2022
Hyposmia Trial in Solna (Nose plug, Regular olfactory training)
Recruiting
- Hyposmia
- Nose plug
- Regular olfactory training
-
Solna, Stockholm, SwedenKarolinska Institutet
Nov 16, 2023
Smell Dysfunction, Taste Disorders, Taste Disorder, Secondary, Sweet Trial (Insulin aspart)
Not yet recruiting
- Smell Dysfunction
- +4 more
- Insulin aspart
- (no location specified)
Oct 30, 2021
Anosmia Trial (platelets rich plasma)
Not yet recruiting
- Anosmia
- platelets rich plasma
- (no location specified)
May 25, 2022
Smell Dysfunction, Olfactory Disorder, Long COVID Trial (Trigeminal Nerve Stimulation (TNS), Active Smell Training (ST), Placebo
Not yet recruiting
- Smell Dysfunction
- +2 more
- Trigeminal Nerve Stimulation (TNS)
- +2 more
- (no location specified)
May 9, 2023
Covid19, Anosmia, Olfactory Disorder Trial in Saint Louis (Theophylline Powder)
Completed
- Covid19
- +7 more
- Theophylline Powder
-
Saint Louis, MissouriWashington University School of Medicine in Saint Louis
Feb 1, 2022
COVID-19 Trial in Copenhagen (Olfactory training with essential oils, Olfactory training with fragrance-free oils)
Recruiting
- COVID-19
- Olfactory training with essential oils
- Olfactory training with fragrance-free oils
-
Copenhagen, DenmarkDepartment of Otorhinolaryngology, Head and Neck Surgery & Audio
Sep 13, 2022
Anosmia, Covid19 Trial in New York (Omega-3 Fatty Acid Supplement, Placebo/Control)
Completed
- Anosmia
- Covid19
- Omega-3 Fatty Acid Supplement
- Placebo/Control
-
New York, New YorkMount Sinai Hospital
Jan 14, 2022
SARS-CoV-2 Acute Respiratory Disease Trial in Paris (Clinical examination, Blood collection, Olfactory evoked potentials)
Recruiting
- SARS-CoV-2 Acute Respiratory Disease
- Clinical examination
- +6 more
-
Paris, FranceHôpital Lariboisière
Aug 16, 2022
Type 2 Diabetes Trial in Lakewood (Bexagliflozin)
Completed
- Type 2 Diabetes Mellitus
-
Lakewood, ColoradoDenver Clinical Research Unit
May 26, 2021
Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via
Terminated
- Graves' Ophthalmopathy (GO)
- RVT-1401 (Administered via subcutaneous injection)
- Placebo (Administered via subcutaneous injection)
-
Beverly Hills, California
- +24 more
Aug 26, 2022
Hemorrhagic Hereditary Telangiectasia (HHT) Trial in Bron, Clermont-Ferrand, Montpellier (Protopic® (Tacrolimus) 0.1% ointment,
Completed
- Hemorrhagic Hereditary Telangiectasia (HHT)
- Protopic® (Tacrolimus) 0.1% ointment
- Placebo
-
Bron, France
- +2 more
Jun 12, 2020
Malignant Pleural Mesothelioma Trial in Worldwide (MORAb-009 (Amatuximab), Pemetrexed, Cisplatin)
Completed
- Malignant Pleural Mesothelioma
- MORAb-009 (Amatuximab)
- +2 more
-
Birmingham, Alabama
- +27 more
Aug 24, 2022
Cocaine Dependence Trial in United States (Buprenorphine + Naltrexone, Placebo + Naltrexone)
Completed
- Cocaine Dependence
- Buprenorphine + Naltrexone
- Placebo + Naltrexone
-
Los Angeles, California
- +10 more
Oct 1, 2021
Menopause Hot Flashes Trial in United States (MT-8554 1mg, MT-8554 5mg, MT-8554 10mg)
Completed
- Menopause Hot Flashes
- MT-8554 1mg
- +3 more
-
Birmingham, Alabama
- +62 more
Dec 6, 2021